Skip to main content

Table 1 (abstract P13). Baseline characteristics of enrolled patients and comparison between preperiod and postperiod

From: Sepsis 2019

 

Pre (N = 317)

Post (N = 231)

P value

Age (years), median (IQR)

71 (60-79)

73 (62-82)

0.148

Male, no. (%)

158 (49.8)

115 (49.8)

0.996

Initial q-SOFA ≥2, no. (%)

317 (100)

231 (100)

 

Site of infection, no (%)

 Respiratory

198 (62.5)

135 (58.4)

0.315

 Genitourinary

83 (26.2)

61 (26.4)

0.572

 Gastrointestinal

22 (6.9)

17 (7.4)

 

 Hepatobiliary

8 (2.5)

6 (2.6)

 

 Central nervous

7 (2.2)

5 (2.2)

 

 Cardiovascular

6 (1.9)

5 (2.2)

 

 Skin and soft tissue

4 (1.3)

3 (1.3)

 

 Other sites

11 (3.5)

8 (3.5)

 

 Unknown

8 (2.5)

6 (2.6)

 

SOFA score, mean ± SEM

7.8 ± 0.4

8.0 ± 0.4

0.425

Septic shock, no. (%)

135 (42.6%)

108 (46.8%)

0.232

Disposition in ED, no (%)

 Intensive care unit admission

107 (33.8)

75 (32.5)

0.417

 General ward admission

116 (36.6)

83 (35.9)

 

 Death in ED

15 (4.7)

11 (4.8)

 

 Others

79 (24.9)

62 (26.8)

 

Length of stay (days), median (IQR)

9 (4-13)

10 (4-18)

0.436

Length of antibiotics (days), median

8 (3-13)

9 (4-16)

0.361

Compliance with recommendations, no. (%)

85 (26.8)

122 (52.8)

<0.001

 Broad-spectrum antibiotics ≤3 hours

185 (58.4)

160 (69.3)

0.02

 Blood culture before antibiotics

247 (77.9)

198 (85.7)

0.04

 Appropriate fluid resuscitation

215 (67.8)

167 (72.3)

0.206

 Lactate measurement ≥2 within 6 hours

116 (36.6)

205 (88.7)

<0.001

Time to 1st antibiotics (min), median (IQR)

121 (72-188)

112 (68-180)

0.349

7-day mortality, no (%)

44 (13.9)

30 (13.0)

0.315

14-day mortality, no (%)

87 (27.4)

62 (26.8)

0.412

28-day mortality, no (%)

118 (37.2)

74 (32.0)

0.08